Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review
Malignant melanoma of the genital tract is a rare disease that is usually diagnosed by chance. When a definite diagnosis is delayed, the prognosis is very poor without standardized treatment. Herein, we describe a 40-year-old patient who presented with a history of bloody vaginal discharge for 7 months. Gynecological examination showed an exophytic, hard and pigmented cervical mass involving the upper vagina. The patient was diagnosed with cervical melanoma after a punch biopsy and underwent a radical hysterectomy, upper vaginectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy. After surgeries, the patient underwent 2-cycles of adjuvant immunotherapy with pembrolizumab, but died within 8 months. In this report, treatment with pembrolizumab after radical surgery was not effective for this patient who had a primary cervical melanoma that metastasized to bone and lung tissue. We do not know why pembrolizumab was ineffective for this patient, but there are several possible explanations; further research is needed..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Obstetrics & Gynecology Science - 61(2018), 4, Seite 524-528 |
| Sprache: |
Englisch ; Koreanisch |
|---|
| Beteiligte Personen: |
Myeong Seon Kim [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Antibodies, monoclonal, humanized |
|---|
| doi: |
10.5468/ogs.2018.61.4.524 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ007193912 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ007193912 | ||
| 003 | DE-627 | ||
| 005 | 20230309214526.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5468/ogs.2018.61.4.524 |2 doi | |
| 035 | |a (DE-627)DOAJ007193912 | ||
| 035 | |a (DE-599)DOAJa22dbc45b88947229c9049b4858a2dc7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a kor | ||
| 050 | 0 | |a RG1-991 | |
| 100 | 0 | |a Myeong Seon Kim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Malignant melanoma of the genital tract is a rare disease that is usually diagnosed by chance. When a definite diagnosis is delayed, the prognosis is very poor without standardized treatment. Herein, we describe a 40-year-old patient who presented with a history of bloody vaginal discharge for 7 months. Gynecological examination showed an exophytic, hard and pigmented cervical mass involving the upper vagina. The patient was diagnosed with cervical melanoma after a punch biopsy and underwent a radical hysterectomy, upper vaginectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy. After surgeries, the patient underwent 2-cycles of adjuvant immunotherapy with pembrolizumab, but died within 8 months. In this report, treatment with pembrolizumab after radical surgery was not effective for this patient who had a primary cervical melanoma that metastasized to bone and lung tissue. We do not know why pembrolizumab was ineffective for this patient, but there are several possible explanations; further research is needed. | ||
| 650 | 4 | |a melanoma | |
| 650 | 4 | |a pembrolizumab | |
| 650 | 4 | |a antibodies, monoclonal, humanized | |
| 650 | 4 | |a uterine cervical neoplasms | |
| 653 | 0 | |a Gynecology and obstetrics | |
| 700 | 0 | |a Chel-Hun Choi |e verfasserin |4 aut | |
| 700 | 0 | |a Tae-Joong Kim |e verfasserin |4 aut | |
| 700 | 0 | |a Jeong-Won Lee |e verfasserin |4 aut | |
| 700 | 0 | |a Jeeyun Lee |e verfasserin |4 aut | |
| 700 | 0 | |a Duk-Soo Bae |e verfasserin |4 aut | |
| 700 | 0 | |a Byoung-Gie Kim |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Obstetrics & Gynecology Science |d Korean Society of Obstetrics and Gynecology, 2018 |g 61(2018), 4, Seite 524-528 |w (DE-627)DOAJ000106097 |x 22878580 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2018 |g number:4 |g pages:524-528 |
| 856 | 4 | 0 | |u https://doi.org/10.5468/ogs.2018.61.4.524 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a22dbc45b88947229c9049b4858a2dc7 |z kostenfrei |
| 856 | 4 | 0 | |u http://ogscience.org/upload/pdf/ogs-61-524.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2287-8572 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2287-8580 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2018 |e 4 |h 524-528 | ||